On this episode of The 100, "God Complex," Abby and the others deal with a crushing blow, Clarke prepares to make the ultimate sacrifice, and Jaha finds new evidence that leads him and Kane in search of the Second Dawn.
Nobody on the island (with the exceptions of Emori and Murphy) feels good about experimenting on Baylis. But the killer "death" wave of radiation is due to hit in ten days. Luna's stem cells grafted successfully, and Baylis is generating Nightblood on his own, so it's now or never. Clark remains the most vocal supporter of turning the guy into a deep-fried Twinkie. Murphy reminds everyone that the black rain already killed 18 people in Arkadia, so if the Nightblood is going to help him survive the next storm, he's ready to find out.
Epic Fail
Things start out promising with Baylis showing no ill-effects, but the experiment eventually goes south with Baylis being scorched, screaming in pain and vomiting up blood. He dies in the chamber. This is a huge bummer since the Nightblood was the only plan, and they tortured and killed a man for no good reason.
From the Ashes
Back at Arkadia, the survivors of the black rain hold a memorial for the dead. Jasper remains footloose and fancy free, showing no concern about what lays ahead. He decides to ditch and go on a walkabout, and Bellamy, worried about his friend's ambivalence about possibly dying at any time, decides to tag along.
Niyah performs her own little ritual, stating "From the earth we will grow. From the ashes we will rise." Jaha overhears Niyah and asks where she heard that phrase. She tells him he'll have to ask a Flamekeeper. All she knows is that's whatGrounders sayto ready their dead for the fire.
Jaha goes to Kane. He's now convinced that the bunker Clarke, Bellamy and himself found was a decoy, meant for members of the Second Dawn who hadn't yet ascended to level 12. It was a way to prevent the real bunker from being overrun. Jaha believes there's a reason "From the ashes we will rise" became a Grounders' prayer. Just like a corporate logo became a sacred symbol.
Jaha's theory is enough of a reason for Kane to decide to reach out to Indra to try and find out Gaia's whereabouts. Jaha is eager to assemble a team, but Kane warns him Polis is a war zone, and they won't be welcome. Jaha plans to travel light, and this mission calls for thinkers, not warriors.
First Survival Then Humanity
At the lab, Jackson figures out what may have caused their experiment to fail. They can try again, but they need another test subject. Luna isn't down with going out to hunt for another Grounder, pointing out that even Baylis honored the dead by wearing the stones of his Rock Line ancestors. After putting the pieces together, Clarke realizes the man wasn't Baylis after all and asks Emori who they just killed. Emori yells to Murphy to destroy the machine and tries to flee but is held by Roan.
The others lock up Emori and Murphy, but Raven isn't okay with the prospect of putting Emori in the radiation chamber. Clarke doesn't know what else to do, and Roan says they don't have a choice. Raven believes there has to be another way to solve their problem that doesn't make them murderers, but the only thing Abby knows for sure is if they do nothing, everyone dies.
Abby orders Jackson to prep Luna for another extraction, but she refuses. She won't let her blood kill anymore innocent people. She's set to go out into the black rain so nobody can follow, but Roan won't allow her to leave. Luna questions if there's any line they won't cross in order to survive. Roan responds that survival requires sacrifice. If Emori dies saving the world, that's a good death.
Luna is wounded from the bone marrow biopsy, and Roan doesn't want to fight her, but she leaves him no choice. Luna isn't much of a match, and Roan renders her unconscious. Raven is mortified that Abby plans to strap Luna down and forcibly take her marrow and equates Clarke and the others with the scientists at Mt. Weather.
Roan gives Clarke a pep talk. She's filled with doubt about whether they're doing the right thing. Roan says that certainty is a luxury leaders can't afford. Clarke may not be a king, but she's a born leader, and she doesn't back down when things get hard. Roan is certain one day people will thank her for what she's doing on the island. Clarke doesn't think Murphy or Emori will, but Roan thinks they will if it works. Clarke worries what happens if it doesn't, but then it's kind of a moot point since they'll all be dead.
The time comes to put Emori in the chamber, and Murphy begs Clarke not to do it. When that doesn't change her mind, Murphy promises Clarke that if Emori dies, she's next. Abby can't bring herself to inject Emori with the Nightblood, leaving it up to Clarke to do her dirty work. But, instead, Clarke injects herself.
Abby refuses to let Clarke go in the chamber, telling her daughter she had a vision that Clarke would die, just like Raven's vision of the rocket. Abby destroys the chamber, smashing it so until it's useless.
It's the End of the World and Jasper Feels Fine
Bellamy and Jasper wander into the forest, and Bellamy grows tired of Jasper's jokes about the end of the world. Jasper tells Bellamy he's trying to help him. The clock has been ticking since they landed on Earth. They're all living on borrowed time. Bellamy wonders if that's what Jasper truly believes, why is he wasting it, but Jasper remains steadfast that he's not, it's Bellamy who is.
Bellamy keeps beating himself up about all the terrible things that he's done, and even if he thought he had good reasons, in the end, nobody gives a damn about Bellamy's reasons. No matter how much Bellamy punishes himself, it won't bring anyone back. Jasper says they can spend their last days wallowing, or they can do whatever they want.
Bellamy and Jasper return to Arkadia, and everybody's partying. Jasper's brought back some "magic beans" (hallucinogenic nuts) to amp up the festivities. Bellamy makes a half-hearted effort to be a buzz kill, but peer pressure wins out.
The 12th Seal
Kane, Jaha and Monty arrive in Polis and discover the black rain fell there too, leaving a number of casualties. They are also greeted by a small army ofTrikru led by Indra. Kane thanks her for meeting with him, but she punches him in the face. Indra's not interested in pleasantries, she just wants to know why Kane is in Polis. As the ally of her enemy, he and Skaikru are now her enemies as well.
Kane tries to explain that Skaikru is still trying to save everyone, but all Indra sees is that they made a truce with Azgeda, seemingly leaving Trikru to fend for themselves. Kane emphasizes that they must all work together, and he needs to see Gaia since she could be the key to saving them all.
Luckily, Gaia is in Polis, and Indra takes the men to see her. Monty spots a tattoo on her shoulder, and it's the same symbol on theseal that Jaha took from the bunker. According to Gaia and Indra, it's the holy symbol of their order. Gaia reveals the symbol adorns the crypt of the first Commander, Becca Pramheda.
The crypt is located in a temple controlled by the Azgeda. Indra is ready to fight to get in, but Kane says they have the royal seal/medallion (given to them by Roan) and don't have to, especially since Azgeda is Skaikru's ally. Indra thinks Kane is foolish to assume Azgeda will honor the medallion. The closer they get to Praimfaya, the less alliances mean.
They arrive at the temple, Kane shows themedallion and they are given permission to pass. But Indra guns down all of the guards anyway. If there is a bunker, she's determined Azgeda will never see the inside.
They head inside the temple, and Gaia shows them the symbol which is located beneath the alter. Jaha and Kane try to figure out how to open the crypt, and they don't have much time with more Azgeda returning to the temple. Monty figures out that "From the ashes we will rise" isn't just a motto, it's instructions. They drop theseal into fire, and it becomes the 12th seal. They open the crypt and find a staircase. At the bottom, there's another bunker.
Who will go into the bunker? Who will be left out? Is there still a chance Abby will find another solution? Let us know what you think in the comments section below.
(Image Courtesy of The CW)
Read more:
'The 100' Recap: Jaha Searches for the Second Dawn - BuddyTV (blog)
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021